Molecular and functional analysis identifies ALK-1 as the predominant cause of pulmonary hypertension related to hereditary haemorrhagic telangiectasia
暂无分享,去创建一个
R. Trembath | R. Harrison | N. Morrell | H. Olschewski | V. McLaughlin | R. Machado | T. Laitinen | C. Elliott | F. Kermeen | I. Robbins | S. Abdalla | J. Flanagan | J. Rowell | E. Gruenig | M. Sankelo | V. Mclaughlin | R. Harrison | E. Gruenig | H. Olschewski | R. E. Harrison | J. A. Flanagan | M. Sankelo | R. D. Machado | I. M. Robbins | H. Olschewski | V. McLaughlin | E. Gruenig | M. Halme | A. Räisänen-Sokolowski | T. Laitinen | N. W. Morrell | N. W. Morrell | H. Olschewski
[1] L. Korniszewski,et al. [Genetics of primary pulmonary hypertension]. , 2004, Polskie Archiwum Medycyny Wewnetrznej.
[2] S. Mundlos,et al. Mutations in bone morphogenetic protein receptor 1B cause brachydactyly type A2 , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[3] D. Bonneau,et al. Visceral manifestations in hereditary haemorrhagic telangiectasia type 2 , 2003, Journal of medical genetics.
[4] J. Massagué,et al. Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus , 2003, Cell.
[5] C. Deber,et al. Disease-associated mutations in conserved residues of ALK-1 kinase domain , 2003, European Journal of Human Genetics.
[6] C. Mummery,et al. Hereditary hemorrhagic telangiectasia: an update on transforming growth factor beta signaling in vasculogenesis and angiogenesis. , 2003, Cardiovascular research.
[7] S. Hodge,et al. BMPR2 germline mutations in pulmonary hypertension associated with fenfluramine derivatives , 2002, European Respiratory Journal.
[8] E. Buscarini,et al. Identification of 13 new mutations in the ACVRL1 gene in a group of 52 unselected Italian patients affected by hereditary haemorrhagic telangiectasia , 2002, Journal of medical genetics.
[9] N. Rudarakanchana,et al. Functional analysis of bone morphogenetic protein type II receptor mutations underlying primary pulmonary hypertension. , 2002, Human molecular genetics.
[10] F. Tsai,et al. Mutation analysis of a family with hereditary hemorrhagic telangiectasia associated with hepatic arteriovenous malformation. , 2001, Journal of the Formosan Medical Association = Taiwan yi zhi.
[11] J Kuriyan,et al. The TGF beta receptor activation process: an inhibitor- to substrate-binding switch. , 2001, Molecular cell.
[12] M. Humbert,et al. Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia. , 2001, The New England journal of medicine.
[13] K. Brusgaard,et al. Mutations in the ALK-1 gene and the phenotype of hereditary hemorrhagic telangiectasia in two large Danish families. , 2001, American journal of medical genetics.
[14] M. Humbert,et al. Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-β family , 2000, Journal of medical genetics.
[15] S. Hodge,et al. Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene. , 2000, American journal of human genetics.
[16] R. Trembath,et al. Heterozygous germline mutations in BMPR2, encoding a TGF-β receptor, cause familial primary pulmonary hypertension , 2000, Nature Genetics.
[17] S. Hallam,et al. Clinical manifestations in a large hereditary hemorrhagic telangiectasia (HHT) type 2 kindred. , 2000, American journal of medical genetics.
[18] N. Pece-Barbara,et al. Analysis of ALK-1 and endoglin in newborns from families with hereditary hemorrhagic telangiectasia type 2. , 2000, Human molecular genetics.
[19] A. Guttmacher,et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). , 2000, American journal of medical genetics.
[20] Morgan Huse,et al. Crystal Structure of the Cytoplasmic Domain of the Type I TGF β Receptor in Complex with FKBP12 , 1999, Cell.
[21] J. Wrana,et al. Endoglin Is an Accessory Protein That Interacts with the Signaling Receptor Complex of Multiple Members of the Transforming Growth Factor-β Superfamily* , 1999, The Journal of Biological Chemistry.
[22] D. W. Johnson,et al. The activin receptor-like kinase 1 gene: genomic structure and mutations in hereditary hemorrhagic telangiectasia type 2. , 1997, American journal of human genetics.
[23] D. W. Johnson,et al. Mutations in the activin receptor–like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2 , 1996, Nature Genetics.
[24] J. Massagué,et al. Identification of human activin and TGFβ type I receptors that form heteromeric kinase complexes with type II receptors , 1993, Cell.
[25] M. Porteous,et al. Hereditary haemorrhagic telangiectasia: a clinical analysis. , 1992, Journal of medical genetics.
[26] R. Sapru,et al. Pulmonary hypertension in patients with pulmonary arteriovenous fistulae. , 1969, British heart journal.
[27] J. Massagué,et al. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. , 2003, Cell.
[28] S. Kenwrick,et al. Disease-associated mutations in L1 CAM interfere with ligand interactions and cell-surface expression. , 2002, Human molecular genetics.
[29] J. Doré,et al. Transforming growth factor beta receptor signaling and endocytosis are linked through a COOH terminal activation motif in the type I receptor. , 2001, Molecular Biology of the Cell.
[30] D. W. Johnson,et al. Novel missense and frameshift mutations in the activin receptor-like kinase-1 gene in hereditary hemorrhagic telangiectasia. Mutations in brief no. 164. Online. , 1998, Human mutation.
[31] D. Marchuk,et al. Novel missense and frameshift mutations in the activin receptor‐like kinase‐1 gene in hereditary hemorrhagic telangiectasia , 1998 .
[32] D. W. Johnson,et al. Endoglin, a TGF-β binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1 , 1994, Nature Genetics.
[33] J. Newman,et al. Familial primary pulmonary hypertension: clinical patterns. , 1984, The American review of respiratory disease.